(19)
(11) EP 0 988 857 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.05.2006 Bulletin 2006/18

(45) Mention of the grant of the patent:
28.12.2005 Bulletin 2005/52

(21) Application number: 99116765.1

(22) Date of filing: 30.08.1999
(51) International Patent Classification (IPC): 
A61K 9/00(1968.09)
 A61K 31/195(1985.01)

(54)

Nutrient infusion preparation

Nährstoffinfusionspräparat

Préparation nutritive pour perfusion parentérale

(84) Designated Contracting States:
DE FR GB IT

(30) Priority: 31.08.1998 JP 24610898

(43) Date of publication of application:
29.03.2000 Bulletin 2000/13

(73) Proprietor: NIPRO CORPORATION
Kita-ku, Osaka-shi (JP)

(72) Inventors:
  • Namba, Ryohei, c/o Nipro Corporation
    Osaka-shi, Osaka-fu 531-8510 (JP)
  • Yamashita, Shunzo, c/o Nipro Corporation
    Osaka-shi, Osaka-fu 531-8510 (JP)
  • Kikuchi, Takeo, c/o Nipro Corporation
    Osaka-shi, Osaka-fu 531-8510 (JP)
  • Sato, Makoto, c/o Nipro Corporation
    Osaka-shi, Osaka-fu 531-8510 (JP)

(74) Representative: Albrecht, Thomas et al
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)


(56) References cited: : 
EP-A- 0 625 313
FR-A- 2 455 888
US-A- 5 662 932
US-A- 5 753 241
 EP-A- 0 711 566
FR-A- 2 497 668
US-A- 5 674 527
   
  • PATENT ABSTRACTS OF JAPAN vol. 1996, no. 11, 29 November 1996 (1996-11-29) & JP 08 191873 A (NISSHO CORP), 30 July 1996 (1996-07-30)
  • PATENT ABSTRACTS OF JAPAN vol. 1996, no. 11, 29 November 1996 (1996-11-29) & JP 08 182739 A (NISSHO CORP), 16 July 1996 (1996-07-16)
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).